Summary Emerging SARS-CoV-2 sub-lineages like XBB. 1.5, XBB. 1.16, EG. 5, HK. 3 (FLip),
and XBB. 2.3 and the variant BA. 2.86 have recently been identified. Understanding the …

Since the SARS-CoV-2 Omicron virus has gained dominance worldwide, its continual
evolution with unpredictable mutations and patterns has revoked all authorized …

Several studies have suggested the imprinting of SARS-CoV-2 immunity by original immune
challenge without addressing the formation of the de novo response to successive antigen …

Introduction This study sought to elucidate the long-term antibody responses to the Moderna
mRNA-1273 COVID-19 vaccine within a Ugandan cohort, aiming to contribute to the sparse …

While the World Health Organization (WHO) has de-escalated coronavirus disease 2019
(COVID-19) from a global health emergency, ongoing discussions persist as new viral …

Most of vaccinees and COVID-19 convalescents can build effective anti-SARS-CoV-2
humoral immunity, which helps preventing infection and alleviating symptoms. However …

Cancer patients (CPs), being immunosuppressed due to the treatment received or to the
disease itself, are more susceptible to infections and their potential complications, showing …

Immunity following infection and vaccination with the SARS-CoV-2 Omicron variant is poorly
understood. The aim was to investigate immunity assessed with antibody response …

To accommodate waning COVID-19 vaccine immunity to emerging SARS-CoV-2 variants,
variant-adapted mRNA vaccines have been introduced. Here, we examine serological …

The review by Reeg DB and colleagues from the Freiburg University Medical Center was
published in early January 2023 [1], addressing the often forgotten important issue of …